LENZ THERAPEUTICS INC (LENZ) Forecast, Price Target & Analyst Ratings

NASDAQ:LENZUS52635N1037

Current stock price

9.9 USD
+0.27 (+2.8%)
At close:
9.9712 USD
+0.07 (+0.72%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LENZ THERAPEUTICS INC (LENZ).

Forecast Snapshot

Consensus Price Target

Price Target
$39.10
+ 294.95% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$1.05
Revenue Estimate
2.246M

ChartMill Buy Consensus

Rating
87.69%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$39.10
Upside
+ 294.95%
From current price of $9.90 to mean target of $39.10, Based on 13 analyst forecasts
Low
$20.20
Median
$34.68
High
$63.00

Price Target Revisions

1 Month
-23.59%
3 Months
-27.67%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for LENZ. The average price target is 39.1 USD. This implies a price increase of 294.95% is expected in the next year compared to the current price of 9.9.
The average price target has been revised downward by 27.67% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

LENZ Current Analyst RatingLENZ Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

LENZ Historical Analyst RatingsLENZ Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
87.69%
LENZ was analyzed by 13 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about LENZ.
In the previous month the buy percentage consensus was at a similar level.
LENZ was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-26CitigroupMaintains Buy -> Buy
2026-03-25B of A SecuritiesMaintains Buy -> Buy
2025-10-20Raymond JamesReiterate Outperform -> Outperform
2025-10-10Piper SandlerMaintains Overweight -> Overweight
2025-08-01CitigroupMaintains Buy -> Buy
2025-08-01HC Wainwright & Co.Maintains Buy -> Buy
2025-07-31Raymond JamesMaintains Outperform -> Outperform
2025-07-31CitigroupMaintains Buy -> Buy
2025-07-28HC Wainwright & Co.Maintains Buy -> Buy
2025-05-08HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-16HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-14Piper SandlerMaintains Overweight -> Overweight
2025-03-20CitigroupMaintains Buy -> Buy
2024-11-07HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-27Raymond JamesInitiate Outperform
2024-08-15Piper SandlerMaintains Overweight -> Overweight
2024-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-12HC Wainwright & Co.Initiate Buy
2024-04-15Leerink PartnersInitiate Outperform
2024-04-15William BlairInitiate Outperform
2024-04-10CitigroupInitiate Buy
2024-03-27Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$1.05
Revenue Estimate
2.246M
Revenue Q2Q
N/A
EPS Q2Q
-98.34%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
-32.45%
Revenue (3 Months)
-38.31%
EPS (1 Month)
-11.29%
EPS (3 Months)
-12.43%

Next Earnings Summary

LENZ is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -1.05 USD and the consensus revenue estimate is 2.25M USD.
The next earnings revenue estimate has been revised downward by 38.31% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
LENZ revenue by date.LENZ revenue by date.
19.088M28.89M
51.35%
86.187M
198.33%
169.12M
96.22%
333.38M
97.13%
426.79M
28.02%
542.35M
27.08%
613.1M
13.05%
679.06M
10.76%
EBITDA
YoY % growth
LENZ ebitda by date.LENZ ebitda by date.
-70.703M
31.55%
-58.552M
17.19%
-90.851M
-55.16%
-102.423M
-12.74%
-108.625M
-6.06%
-45.795M
57.84%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
LENZ ebit by date.LENZ ebit by date.
-73.11M
30.79%
-58.61M
19.83%
-91.138M
-55.50%
-99.815M
-9.52%
-38.671M
61.26%
50.058M
229.45%
141.2M
182.07%
234.37M
65.98%
302.52M
29.08%
361.12M
19.37%
414.88M
14.89%
Operating Margin
LENZ operating margin by date.LENZ operating margin by date.
N/AN/A-477.46%-345.50%-44.87%29.60%42.35%54.91%55.78%58.90%61.10%
EPS
YoY % growth
LENZ eps by date.LENZ eps by date.
-15.33
-18.38%
-4.77
68.88%
-2.79
41.51%
-3.87
-38.62%
-2.69
30.52%
-0.61
77.32%
3.94
746.13%
5.99
52.07%
8.83
47.53%
7.84
-11.20%
8.58
9.43%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.05
-98.34%
-0.96
-88.31%
-0.92
-56.41%
-0.95
18.46%
-0.47
55.36%
-0.29
70.26%
-0.14
84.53%
0.01
101.08%
Revenue
Q2Q % growth
2.246M3.14M
-37.20%
9.377M
-24.98%
13.706M
763.10%
23.48M
945.41%
7.844M
149.81%
12.189M
29.99%
17.33M
26.44%
EBITDA
Q2Q % growth
-26.015M
-53.98%
-27.879M
-65.93%
-25.991M
-38.94%
-16.431M
56.96%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-34.103M
-101.42%
-31.22M
-85.21%
-30.602M
-62.03%
-32.419M
15.71%
-11.016M
67.70%
-6.018M
80.72%
-1.326M
95.67%
3.366M
110.38%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LENZ Yearly Revenue VS EstimatesLENZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
LENZ Yearly EPS VS EstimatesLENZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 -10 -15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.23%
EPS Next 5 Year
32.90%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
105.45%
Revenue Next 5 Year
85.36%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
13.54%
EBIT Next 5 Year
N/A

LENZ THERAPEUTICS INC / LENZ Forecast FAQ

Can you provide the average price target for LENZ THERAPEUTICS INC stock?

13 analysts have analysed LENZ and the average price target is 39.1 USD. This implies a price increase of 294.95% is expected in the next year compared to the current price of 9.9.

Can you provide the upcoming earnings date for LENZ THERAPEUTICS INC?

LENZ THERAPEUTICS INC (LENZ) will report earnings on 2026-05-04.

What are the consensus estimates for LENZ THERAPEUTICS INC (LENZ) next earnings?

The consensus EPS estimate for the next earnings of LENZ THERAPEUTICS INC (LENZ) is -1.05 USD and the consensus revenue estimate is 2.25M USD.

Can you provide the expected long term growth rate for LENZ THERAPEUTICS INC stock?

The expected long term growth rate for LENZ THERAPEUTICS INC (LENZ) is 105.45%.